Why Did Jefferies Give Easterly Government Properties Inc (DEA) Stock Buy Rating?
Jefferies has recently raised Easterly Government Properties Inc (DEA) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on August 16, 2023, RBC Capital Mkts had reduced the stock from a Sector Perform to Underperform, setting a price target of $13 for DEA stock. Compass Point also raised Buy rating […]
What’s Fueling Revance Therapeutics Inc (RVNC) Stock’s -17.60% Loss Below Its 200-Day SMA?
Mizuho has recently reduced Revance Therapeutics Inc (RVNC) stock to Neutral rating, as announced on January 29, 2024, according to Finviz. Earlier, on January 9, 2024, Goldman had reduced the stock from a Buy to Neutral, setting a price target of $8 for RVNC stock. Exane BNP Paribas also raised Neutral rating with a price […]
Vir Biotechnology Inc (VIR) Posted -678.40% Profit Margin Last Year—Can It Hold Up?
JP Morgan has recently reduced Vir Biotechnology Inc (VIR) stock to Neutral rating, as announced on January 29, 2024, according to Finviz. Earlier, on September 8, 2023, BofA Securities had reduced the stock from a Buy to Neutral, setting a price target of $14 for VIR stock. JP Morgan also raised Overweight rating with a […]
Noble Corporation PLC (NE) Reported a 22.86% Operating Margin Last Year—What’s the Real Story?
The Benchmark Company has recently reduced Noble Corporation PLC (NE) stock to Hold rating, as announced on October 15, 2024, according to Finviz. Earlier, on December 1, 2023, Susquehanna had resumed the stock to Neutral, setting a price target of $52. CapitalOne also initiated Overweight rating with a price target of $62. Additionally, Citigroup initiated […]
What’s Driving Builders FirstSource, Inc. (BLDR) Stock’s -3.22% Plunge Over the Past Month?
UBS has recently initiated Builders FirstSource, Inc. (BLDR) stock to Buy rating, as announced on October 25, 2024, according to Finviz. Earlier, on October 10, 2024, Goldman had initiated the stock to Buy, setting a price target of $225. Truist also raised Buy rating with a price target of $220. Additionally, Robert W. Baird raised […]
Why Did New York Times Co (NYT) Stock Tumble -0.19% to $52.01?
Deutsche Bank has recently initiated New York Times Co (NYT) stock to Buy rating, as announced on October 9, 2024, according to Finviz. Earlier, on March 12, 2024, Citigroup had initiated the stock to Buy, setting a price target of $52. Argus also raised Buy rating with a price target of $51. Additionally, Barclays raised […]
Analysts Predict a $15 Target for Apple Hospitality REIT Inc (APLE) Stock—What Could Drive It There?
Wedbush has recently initiated Apple Hospitality REIT Inc (APLE) stock to Neutral rating, as announced on June 3, 2024, according to Finviz. Earlier, on January 8, 2024, BofA Securities had reduced the stock from a Buy to Neutral, setting a price target of $18 for APLE stock. Wells Fargo also reduced Equal Weight rating with […]
What’s Behind the 1.72% Gain in NCR Voyix Corp (VYX) Stock? Find Out Now!
Goldman has recently resumed NCR Voyix Corp (VYX) stock to Neutral rating, as announced on October 14, 2024, according to Finviz. Earlier, on June 12, 2024, Stifel had initiated the stock to Buy, setting a price target of $16. Goldman also initiated Neutral rating with a price target of $14. Additionally, Northcoast raised Buy rating […]
Piper Sandler Just Initiated Nektar Therapeutics (NKTR) Stock—What Does This Mean for Investors?
Piper Sandler has recently initiated Nektar Therapeutics (NKTR) stock to Overweight rating, as announced on November 4, 2024, according to Finviz. Earlier, on September 30, 2024, BTIG Research had resumed the stock to Buy, setting a price target of $4. Rodman & Renshaw also initiated Buy rating with a price target of $2. Additionally, JP […]
How Does Montrose Environmental Group Inc (MEG) Stack Up Against Its Industry Peers?
JP Morgan has recently reduced Montrose Environmental Group Inc (MEG) stock to Neutral rating, as announced on November 8, 2024, according to Finviz. Earlier, on November 6, 2024, BofA Securities had reduced the stock from a Buy to Neutral. Evercore ISI also initiated Outperform rating with a price target of $43. Additionally, Stifel resumed Buy […]